Skip to main content

Table 3 Clinical and biological characteristics of the studied population with weight and metabolic syndrome status specification

From: The effects of exercise on C-reactive protein, insulin, leptin and some cardiometabolic risk factors in Egyptian children with or without metabolic syndrome

 

Control children (n = 49) Mean ± SD

Obese children without metabolic syndrome (n = 32) Mean ± SD

Obese childrenwith metabolic syndrome (n = 12) Mean ± SD

Age (y)

10.1 ± 1.21

10.2 ± 1.2

11.04 ± 1.15a, b

Weight (kg)

62.6 ± 4.1 C

50.2 ± 3.7

67.1 ± 6.3 a, b

Height (cm)

146.5 ± 10.3

147.6 ± 7.5

153.9 ± 8.5 a, b

BMI (kg/m2)

27.01 ± 3.9 C

17.2 ± 2.5

29.4 ± 4.8 a, b

Waist circumference

77.3 ± 5.2 C

62.7 ± 6.6

83.25 ± 2.8 a, b

Waist-hip ratio

0.85 ± 0.06

0.83 ± 0.06

0.88 ± 0.05 b

Systolic BP (mmHg)

117.5 ± 6.8 C

109.4 ± 6.9

121.7 ± 7.8 b

diastolic BP (mmHg)

75.5 ± 8.3 C

71.8 ± 6.3

80.4 ± 4.5 a b

Total cholesterol (mg/dL))

178.5 ± 16.8 C

145.2 ± 13.6

177.7 ± 21.9 b

LDL ± C (mg/dL)

107 ± 10.2 C

92.6 ± 14.5

107.5 ± 12.1 b

HDL-C (mg/dL)

45.8 ± 5.9 C

50.5 ± 6.5

32 ±2.7 a, b

Triglyceride (mg/dL)

95.5 (76–135) C

85 (72–123)

118.5 (110–150) a, b

Glucose (mg/dL)

84.9 ± 5.7

84.1 ± 5.2

105.5 ± 11.04 a, b

Insulin ( IU/mL)

14.4 ± 3.9

14.4 ± 4.9

19.3 ± 4.4 a, b

HOMA-IR

2.7 ± 0.9

2.4 ± 0.6

3.3 ± 0.88 a, b

CRP (mg/L)

1.25 ( 0.01-2.6) C

0.2 ( 0.01-1.5)

2.1 (1.2-3.1) a, b

Serum leptin (ng/mL)

9.4 (0.6-36.5) C

4.5 (0.6-12.4)

15.2 (8.3-21.8) a, b

  1. a = significant difference between obese children with and without metabolic syndrome.
  2. b = significant difference between non obese children and obese children with metabolic syndrome.
  3. c = significant difference between non obese children and obese children without metabolic syndrome.